Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Indoco Remedies Limited

Market Cap 2.24TCr 23Cr 20Cr 19Cr 18Cr 33Cr 33Cr 223.53Cr 87Cr 1.08TCr 88Cr 86Cr 3.76TCr P/E Ratio 2026
-15.3x
P/E Ratio 2027 * 32x
Enterprise Value 2.24TCr 23Cr 20Cr 19Cr 18Cr 33Cr 33Cr 223.53Cr 87Cr 1.08TCr 88Cr 86Cr 3.76TCr EV / Sales 2026
0.82x
EV / Sales 2027 * 1.06x
Free-Float
39.06%
Yield 2026
0.12%
Yield 2027 * 0.3%
1 day+18.56%
1 week+17.15%
Current month+15.90%
1 month+6.62%
3 months+23.64%
6 months+2.57%
Current year+3.58%
1 week 198
Extreme 198
245.95
1 month 191
Extreme 191
245.95
Current year 162.19
Extreme 162.19
270
1 year 162.19
Extreme 162.19
349.8
3 years 162.19
Extreme 162.19
415
5 years 162.19
Extreme 162.19
530.25
10 years 132.45
Extreme 132.45
530.25
Manager TitleAgeSince
Chief Executive Officer 56 15/02/2012
Director of Finance/CFO - 02/11/2021
Chief Operating Officer - 01/05/2021
Director TitleAgeSince
Chairman 87 02/07/1963
Director/Board Member 65 30/08/2011
Director/Board Member 56 29/08/2011
Date Insider Type Main position Quantity % Market Cap.
20/25/20
Shanteri Investment Pvt Ltd.
BuyCompany 12,150 0.0132%
19/25/19
Shanteri Investment Pvt Ltd.
BuyCompany 26,000 0.0282%
12/25/12
Shanteri Investment Pvt Ltd.
BuyCompany 2,600 0.0028%
Change 5-day change 1-year change 3-year change Capi.($)
+18.56%+17.15%-16.35%-26.29% 20Cr
+2.23%+3.48%+44.01%+161.49% 1,01300Cr
+0.58%+5.30%+54.75%+50.26% 57TCr
+0.38%+0.47%+18.01%+64.08% 40TCr
-0.37%+4.97%+21.24%+15.95% 32TCr
+0.85%+0.18%+24.50%+14.78% 28TCr
+2.10%+4.92%+25.30%+33.80% 27TCr
+3.68%+1.36%+20.04%+61.16% 18TCr
-0.19%-0.46%-45.32%-48.35% 19TCr
+3.64%-2.42%+15.32%+61.89% 15TCr
Average +3.14%+2.26%+16.15%+38.88% 33.89TCr
Weighted average by Cap. +1.35%+3.99%+29.80%+73.06%

Financials

2026 2027 *
Net sales 1.88TCr 20Cr 17Cr 16Cr 15Cr 28Cr 28Cr 187.62Cr 73Cr 907.51Cr 74Cr 72Cr 3.16TCr 2.11TCr 22Cr 19Cr 18Cr 17Cr 31Cr 31Cr 210.18Cr 81Cr 1.02TCr 83Cr 81Cr 3.53TCr
Net income -73Cr -75.86L -65.83L -60.68L -56.86L -1.06Cr -1.08Cr -7.24Cr -2.8Cr -35Cr -2.85Cr -2.79Cr -121.74Cr 72Cr 75.3L 65.34L 60.23L 56.44L 1.05Cr 1.08Cr 7.19Cr 2.78Cr 35Cr 2.83Cr 2.77Cr 120.84Cr
Net Debt - -
Logo Indoco Remedies Limited
Indoco Remedies Limited is an India-based fully integrated, research-oriented pharmaceutical company. The Company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The Company caters to both Domestic and International markets. Its products include SENSODENT-K, HOMIDE, DEXOREN-S, LORCHEK-MR, SENSOFORM, KIDODENT, NINAF, KARVOL PLUS, CYCLOPAM, LIGNOX+ADRENLINE, NOXA, CITAL-UTI, RENOLEN, REXIDIN-M, CITAL, SENSODENT-KF, CARMICIDE, TOBAREN-DM, FEBREX PLUS, SCABEX, CLOBEN-G, MOFLOREN-BF, OTOREX, ZINCOREN, SENOLIN, LIGNOX, HEMSYL, FEDRIS, REXIDIN, VEPAN, OXIPOD, TURBOCORT, MACUCHEK, and DENTOGEL. The Company has around 11 manufacturing facilities, seven for finished dosage forms (FDFs) and four for active pharmaceutical ingredients (APIs), supported by a research and development center and a clinical research organization facility.
Employees
6,000
Date Price Change Volume
11/26/11 243.00 +18.56% 1,09,72,328
10/26/10 204.96 -0.44% 1,01,738
09/26/09 205.86 +3.17% 1,11,058
08/26/08 199.53 -3.53% 1,51,336
05/26/05 206.84 -3.02% 1,01,213
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
204.96INR
Average target price
276.25INR
Spread / Average Target
+34.78%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INDOCO Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!